Please login to the form below
Biotie
This page shows the latest Biotie news and features for those working in and with pharma, biotech and healthcare.
Acorda acquires Biotie to expand in Parkinson's disease
Strikes $363m deal for Finnish firm. Acorda Therapeutics has agreed to buy Finland's Biotie Therapies in a $363m deal that swells its pipeline of Parkinson's disease (PD) drug candidates. ... Biotie also has a royalty stream from Lundbeck's sales of
Latest news
-
Has the biological revolution in rheumatoid arthritis peaked?
This includes Genmab's CD20 inhibitor ofatumumab; Xencor's CD 19 inhibitor XmAB 5871, Ablynx's TNF-alpha inhibitor ozoralizumab; Biotie Therapies Corp's AOC3 protein inhibitor BTT 1023 and
-
UCB CEO: Patient info more important than transparency
UCB] first embraced open innovation in 2005 really, and we have really turbo-charged it in the last three years,” he said, referencing recent agreements with Biotie.
-
Oncology bias in pharma deals
disease) to Newron Pharmaceuticals, triggered the termination of Biotie Therapeutics' acquisition of Newron. ... immunotherapy in phase III for non-small cell lung cancer. 7. Newron Pharmaceuticals/Biotie Therapeutics.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Latest Intelligence
-
Deal Watch January 2016
410. Biotie Oy/ Acorda. Acquisition company. CNS portfolio includes tozadenant for Parkinson's in p2b .
-
Pharma deals during September 2012
Lundbeck has subscribed for 4.6 per cent of Biotie Therapeutics shares for 10m (25 per cent premium to the subscription price). ... Biotie will receive additional sales milestones on achievement of undisclosed sales target in Japan, increasing total
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Subscribe to our email news alerts
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- MHRA to introduce new UK clinical trials framework
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- 2023 PM Society Awards – winners announced
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- WHO report highlights impact of COVID-19 pandemic on non-communicable diseases
- Critical success factors and the increasing value of rare disease clinical trials
- Quantum Computing, Artificial Intelligence, & Machine Learning for Drug Discovery
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- GSK reports positive phase 3 results for five-in-one meningococcal vaccine candidate
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Ketchum appoints Conor Nash as global chief financial officer and chief operating officer
PMHub
Evoke Mind+Matter
We are Evoke Mind ‘PLUS’ Matter. The ‘plus’ is important to us because we are all about offering more for...
Latest intelligence
- Rare diseases: not so rare after all
- The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
- Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
- Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
